Craft

Predilife

Stock Price

€3.7

2024-10-29

Market Capitalization

€13.6 M

2024-10-29

Revenue

€493 K

FY, 2024

Predilife Summary

Company Summary

Overview
Predilife is a company specializing in statistics and data mining applied to predictive and preventive medicine. It develops MammoRisk, a test allowing breast cancer risk evaluation for women from 40 years old, and DenSeeMammo, software to monitor breast density assessment.
Type
Public
Status
Active
Founded
2004
HQ
Villejuif, FR | view all locations
Website
https://www.predilife.com/home.php
Cybersecurity rating
Sectors

LocationsView all

3 locations detected

  • Villejuif, IDF HQ

    France

    114 Rue Edouard Vaillant

  • Saint-Cloud, IDF

    France

    Avenue du Palais

  • Villejuif, IDF

    France

    39 Rue Camille Desmoulins

Predilife Financials

Summary Financials

Revenue (H1, 2025)
€393.0K
Gross profit (H1, 2025)
€393.0K
Net income (H1, 2025)
(€1.9M)
Cash (H1, 2025)
€230.0K
EBIT (H1, 2025)
(€1.6M)
Enterprise value
$18.2M

Footer menu